SCHEMBL6399671

SCHEMBL6399671

Cc1ccc2[nH]c(C(=O)NNC(=O)c3ccccc3N)cc2c1.O=S(=O)(O)c1ccccc1

nearest known ligand 0.53

Known targets — ChEMBL curated mechanism

BTKCACNA1CCACNA1DCACNA1FCACNA1SCACNA2D1CACNA2D2DRD2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQHRH1HTR2AP2RY12

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.53
POLB P06746 1/20 0.53
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
BCAT1 P54687 5/20 0.48
HDAC2 Q92769 1/20 0.47
PIN1 Q13526 1/20 0.46
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
RXFP1 Q9HBX9 1/20 0.43
GHSR Q92847 2/20 0.43
FLT3 P36888 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6405483 0.96 TP53 (0.50) TP53POLBHDAC3HDAC1BCAT1
SCHEMBL6400705 0.90 TP53 (0.60) TP53POLBHDAC3HDAC1BCAT1
SCHEMBL6401941 0.89 NPC1 (0.49) TP53POLBHDAC3HDAC1BCAT1
SCHEMBL6403704 0.88 TP53 (0.49) TP53POLBHDAC3HDAC1BCAT1
SCHEMBL6404747 0.83 NPC1 (0.51) TP53POLBHDAC3HDAC1BCAT1
SCHEMBL6404295 0.81 BCAT1 (0.59) HDAC3HDAC1BCAT1HDAC2FLT3
SCHEMBL6399035 0.79 NPC1 (0.56) TP53POLBHDAC3HDAC1BCAT1
SCHEMBL6404675 0.79 TP53 (0.67) TP53POLBHDAC3HDAC1HDAC2
SCHEMBL6401651 0.79 BCAT1 (0.48) TP53POLBHDAC3HDAC1BCAT1
SCHEMBL6402485 0.79 NHERF1 (0.60) TP53POLBHDAC3HDAC1BCAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 TP53 1043/4885POLB 4755/4885HDAC3 2153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.